Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Bradley, Drumheller"'
Autor:
Kashif Osmani, Eshana Shah, Bradley Drumheller, Shaun Webb, Manmeet Singh, Paul Rubinstein, John Patrick Galvin, Megan S. Lim, Carlos Murga-Zamalloa
Publikováno v:
Diagnostic Pathology, Vol 17, Iss 1, Pp 1-6 (2022)
Abstract Background Primary intestinal T-cell lymphomas are uncommon malignancies that pose a diagnostic dilemma, because the clinical features and imaging findings commonly overlap with those encountered in inflammatory bowel diseases. Case presenta
Externí odkaz:
https://doaj.org/article/b54c4bd903274693924200c6347f947e
Autor:
Ranran Zhang, Bradley Drumheller, Li‐Ping Wang, Amrom E. Obstfeld, Jonathan I. Lake, Adam Bagg
Publikováno v:
International Journal of Laboratory Hematology. 45:289-296
Autor:
Bradley Drumheller, Kirubel Gebre, Brian Lockhart, Elizabeth Margolskee, Amrom Obstfeld, Michele Paessler, Vinodh Pillai
Publikováno v:
International Journal of Laboratory Hematology. 44:750-758
Autor:
Bradley, Drumheller, Kirubel, Gebre, Brian, Lockhart, Elizabeth, Margolskee, Amrom, Obstfeld, Michele, Paessler, Vinodh, Pillai
Publikováno v:
International journal of laboratory hematologyREFERENCES. 44(4)
Chimeric antigen receptor (CAR) T cell products are available to treat relapsed/refractory B-lymphoblastic leukaemia/lymphoma (B-ALL), diffuse large B-cell lymphoma, mantle-cell lymphoma, and myeloma. CAR products vary by their target epitope and con
Autor:
Mohamed Amgad, Lamees A Atteya, Hagar Hussein, Kareem Hosny Mohammed, Ehab Hafiz, Maha A T Elsebaie, Ahmed M Alhusseiny, Mohamed Atef AlMoslemany, Abdelmagid M Elmatboly, Philip A Pappalardo, Rokia Adel Sakr, Pooya Mobadersany, Ahmad Rachid, Anas M Saad, Ahmad M Alkashash, Inas A Ruhban, Anas Alrefai, Nada M Elgazar, Ali Abdulkarim, Abo-Alela Farag, Amira Etman, Ahmed G Elsaeed, Yahya Alagha, Yomna A Amer, Ahmed M Raslan, Menatalla K Nadim, Mai A T Elsebaie, Ahmed Ayad, Liza E Hanna, Ahmed Gadallah, Mohamed Elkady, Bradley Drumheller, David Jaye, David Manthey, David A Gutman, Habiba Elfandy, Lee A D Cooper
Publikováno v:
GigaScience. 11
Background Deep learning enables accurate high-resolution mapping of cells and tissue structures that can serve as the foundation of interpretable machine-learning models for computational pathology. However, generating adequate labels for these stru
Autor:
Kashif Osmani, Eshana Shah, Bradley Drumheller, Shaun Webb, Manmeet Singh, Paul Rubinstein, John Patrick Galvin, Megan S. Lim, Carlos Murga-Zamalloa
Publikováno v:
Diagnostic pathology. 17(1)
Background Primary intestinal T-cell lymphomas are uncommon malignancies that pose a diagnostic dilemma, because the clinical features and imaging findings commonly overlap with those encountered in inflammatory bowel diseases. Case presentation The
Autor:
Joshua Lewis, Conrad Shebelut, Bradley Drumheller, Xuebao Zhang, Nithya Shanmugam, Michel Attieh, Michael Horwath, Anurag Khanna, Geoffrey Smith, David Gutman
Publikováno v:
American Journal of Clinical Pathology. 158:S12-S12
Current pathologic diagnosis of benign and neoplastic bone marrow disorders relies in part on the microscopic analysis of bone marrow aspirate (BMA) smears and manual counting of nucleated cell populations to obtain a cell differential. This manual p
Autor:
David A. Gutman, Bradley Drumheller, Mohamed Amgad, David L. Jaye, Ahmed A Aljudi, Lee Cooper, Ramraj Chandradevan, Nilakshan Kunananthaseelan
Publikováno v:
Laboratory investigation; a journal of technical methods and pathology
Bone marrow aspirate (BMA) differential cell counts (DCCs) are critical for the classification of hematologic disorders. While manual counts are considered the gold standard, they are labor intensive, time consuming, and subject to bias. A reliable a
Autor:
David Jaye, Bradley Drumheller, Joshua E. Lewis, Conrad W. Shebelut, Nithya Shanmugam, Lee Cooper, Xuebao Zhang, Geoffrey Smith
Publikováno v:
American Journal of Clinical Pathology. 156:S1-S2
Manual microscopic examination of bone marrow aspirate (BMA) smears and counting of cell populations remains the standard of practice for accurate assessment of benign and neoplastic bone marrow disorders. While automated cell classification software
Publikováno v:
Blood. 138:3874-3874
Introduction CAR T-cell therapies are utilized to treat relapsed/refractory B-lymphoblastic leukemia (B-ALL), diffuse large B cell lymphoma, mantle cell lymphoma, and multiple myeloma. CAR T cell expansion kinetics after infusion impact response. How